[News]
- News
2024/02/14
Modalis Reports 2023 Financial Results and Operational Highlights
- News
2023/12/06
Corporate presentation has been updated
- News
2023/11/07
Modalis Reports Third Quarter 2023 Financial Results and Operational Highlights
- News
2023/08/07
Modalis Reports Second Quarter 2023 Financial Results and Operational Highlights
- News
2023/05/13
Abstracts are released on ASGCT website.
- News
2023/05/09
Modalis Reports First Quarter 2023 Financial Results and Operational Highlights
- News
2023/02/13
Modalis Reports 2022 Financial Results and Operational Highlights
- News
2022/11/07
Modalis Reports Third Quarter 2022 Financial Results and Operational Highlights
- News
2022/08/05
Modalis Reports Second Quarter 2022 Financial Results and Operational Highlights
- News
2022/05/26
Presentation at ASGCT
- News
2022/05/09
Modalis Reports First Quarter 2022 Financial Results and Operational Highlights
- News
2022/05/06
Abstracts are released on ASGCT website. [Update May 13]
- News
2022/04/20
Modalis Therapeutics to Present at the ASGCT Annual Meeting
- News
2022/02/14
Modalis Reports 2021 Financial Results and Operational Highlights
- News
2021/11/12
Haru Morita, President and CEO, is scheduled to speak at the CBI Society Lecture (November 19).
- News
2021/11/05
Modalis Reports Third Quarter 2021 Financial Results and Operational Highlights
- News
2021/10/20
New Location Positions Modalis Therapeutics for Pre/Clinical Development and Future Growth
- News
2021/08/05
Modalis Reports Second Quarter 2021 Financial Results and Operational Highlights
- News
2021/06/04
Haru Morita, President and CEO, is scheduled to speak at the LINK-J Symposium “The Frontiers of Drug Discovery” (June 18).
- News
2021/05/06
Modalis Reports First Quarter 2021 Financial Results and Operational Highlights